Com. McClellan starts after election day
This article was originally published in The Gray Sheet
Incoming FDA Commissioner Mark McClellan, MD/PhD, will be sworn in and start at FDA Nov. 8. McClellan, currently a White House health policy advisor, was cleared by the Senate Oct. 17 (1"The Gray Sheet" Oct. 21, 2002, p. 8)...
You may also be interested in...
The Senate ended FDA's longest interim period without a commissioner (21 months) by confirming Mark McClellan, MD/PhD, to the post Oct. 17
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.